Adipose tissue plays an important role in systemic metabolism via the secretion of
adipocytokines and storing and releasing energy. In obesity, adipose tissue becomes …

Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease
worldwide; it ranges from simple steatosis to steatohepatitis (NASH) and, potentially …

Non-alcoholic fatty liver disease (NAFLD) is a clinical condition characterized by lipid
infiltration of the liver, highly prevalent in the general population affecting 25% of adults, with …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Vitamin D is becoming increasingly accepted as an important physiological regulator
outside of its classical role in skeletal homeostasis. A growing body of evidence connects …

The results of randomized controlled trials (RCTs) investigating supplemental vitamin D on
aminotransferases and cardio-metabolic risk factors in subjects with non-alcoholic fatty liver …

Non-alcoholic fatty liver disease (NAFLD) comprises a wide spectrum of hepatic disorders,
from simple steatosis to hepatic necro-inflammation leading to non-alcoholic steatohepatitis …

Over the past few years, growing interest has been shown for the impact of dietary
requirements and nutritional factors on chronic diseases. As a result, nutritional programs …

Background & Aims Serum 25-hydroxyvitamin D [S-25 (OH) D] and nonalcoholic fatty liver
disease (NAFLD) are correlated in many observational studies, whereas the causality of this …

Background Vitamin D deficiency is often reported in people with chronic liver diseases.
Improving vitamin D status could therefore be beneficial for people with chronic liver …